Pharmaceuticals
Japan's midsize drugmakers find niche in richer Southeast Asians
Market set to double by 2030 as economic growth promotes lifestyle diseases
Pharmaceuticals
Business trends
Japan's bigger companies slash tax bills to record low
Overseas operations and accounting specialists reduce burden
Nikkei Markets
Asian equities gain on bets central banks to take supportive steps
China Resources Beer, airlines, real-estate firms among winners
Nikkei Markets
Hong Kong shares track Wall Street higher on stimulus hopes
Cathay Pacific extends gains after changes in senior management ranks
Companies
Sun Pharmaceutical first-quarter profit jumps on US order
Net profit beats estimates, while revenue climbs 16%
Business trends
Japan Inc. casualty of US-China trade war in April-June quarter
Corporations see profit decreases for third straight period as bottom lines drop 14%
Property
Global funds set sights on Japan property market
Aberdeen Standard and KKR see opportunity in low-rate environment
Pharmaceuticals
Japanese drugmaker Santen forays into India
Ophthalmology specialist plans to roll out five drugs in five years
Pharmaceuticals
Lupin first-quarter profit jumps 50% as US drug sales surge
Smaller rival Cipla posts 6% increase in net income
Business trends
Nomura overtakes Goldman to be Japan's No. 2 M&A adviser
Mitsubishi Morgan Stanley leads the pack in first half as appetite grows for global deals
